Latest filings (excl ownership)
8-K
Ashland signs definitive agreement to sell nutraceuticals business to Turnspire Capital Partners
8 May 24
10-Q
2024 Q2
Quarterly report
1 May 24
8-K
Ashland reports financial results1 for second quarter fiscal 2024; issues outlook for third quarter and full-year fiscal 2024
30 Apr 24
8-K
Departure of Directors or Certain Officers
30 Apr 24
8-K
Ashland Board appoints Scott A. Tozier as new director
15 Apr 24
8-K
Departure of Directors or Certain Officers
26 Feb 24
10-Q
2024 Q1
Quarterly report
31 Jan 24
8-K
Ashland reports financial results1 for first quarter fiscal 2024; issues outlook for second quarter and full-year fiscal 2024
30 Jan 24
8-K
Submission of Matters to a Vote of Security Holders
26 Jan 24
ARS
2023 FY
Annual report to shareholders
11 Dec 23
DEFA14A
Additional proxy soliciting materials
11 Dec 23
DEF 14A
Definitive proxy
11 Dec 23
8-K
Departure of Directors or Certain Officers
17 Nov 23
10-K
2023 FY
Annual report
17 Nov 23
8-K
Departure of Directors or Certain Officers
14 Nov 23
8-K
Ashland reports financial results1 for fourth-quarter fiscal 2023; issues outlook for first-quarter fiscal 2024
8 Nov 23
8-K
Results in the fourth-quarter reflect a customer-demand environment that was generally consistent with expectations
1 Nov 23
8-K
Entry into a Material Definitive Agreement
24 Oct 23
8-K
Departure of Directors or Certain Officers
16 Aug 23
10-Q
2023 Q3
Quarterly report
27 Jul 23
8-K
Ashland reports financial results1 for third quarter of fiscal year 2023
25 Jul 23
8-K
Regulation FD Disclosure
28 Jun 23
8-K
Departure of Directors or Certain Officers
26 Jun 23
SD
Conflict minerals disclosure
31 May 23
8-K
Ashland announces 15 percent increase in quarterly dividend, new dividend policy and $100 million share repurchase program
12 May 23
10-Q
2023 Q2
Quarterly report
3 May 23
8-K
Sales of $603 million consistent with the prior-year quarter
2 May 23
8-K
Entry into a Material Definitive Agreement
20 Apr 23
UPLOAD
Letter from SEC
14 Mar 23
CORRESP
Correspondence with SEC
10 Mar 23
UPLOAD
Letter from SEC
1 Mar 23
10-Q
2023 Q1
Quarterly report
1 Feb 23
8-K/A
Submission of Matters to a Vote of Security Holders
31 Jan 23
8-K
Ashland reports financial results1 for first quarter of fiscal year 2023 consistent with previous update
31 Jan 23
8-K
Submission of Matters to a Vote of Security Holders
27 Jan 23
8-K
Regulation FD Disclosure
25 Jan 23
DEFR14A
Revised proxy
16 Dec 22
DEFA14A
Additional proxy soliciting materials
9 Dec 22
DEFR14A
Revised proxy
9 Dec 22
DEFA14A
Additional proxy soliciting materials
6 Dec 22
Latest ownership filings
4
JAMES P. MINICUCCI
20 May 24
4
OSAMA M MUSA
9 May 24
4
Ashish K Kulkarni
8 May 24
3
Ashish K Kulkarni
8 May 24
144
Notice of proposed sale of securities
7 May 24
SC 13D/A
EMINENCE CAPITAL, LP
25 Apr 24
4
Scott Tozier
17 Apr 24
3
Scott Tozier
17 Apr 24
4
Steven D Bishop
1 Apr 24
4
Sanat Chattopadhyay
1 Apr 24
4
JANICE TEAL
1 Apr 24
4
ROBIN E. LAMPKIN
20 Feb 24
144
Notice of proposed sale of securities
16 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G
DIMENSIONAL FUND ADVISORS LP
9 Feb 24
4
Steven D Bishop
25 Jan 24
4
Suzan F. Harrison
25 Jan 24
4
SUE MAIN
25 Jan 24
4
JANICE TEAL
25 Jan 24
4
Jerome A Peribere
25 Jan 24
4
Sanat Chattopadhyay
25 Jan 24
4
Sergio Pedreiro
25 Jan 24
4
Wetteny Joseph
25 Jan 24
SC 13G/A
BlackRock Inc.
25 Jan 24
4/A
MIN CHONG
11 Jan 24
4
MIN CHONG
4 Jan 24
4
JANICE TEAL
3 Jan 24
4
Steven D Bishop
3 Jan 24
4
ERIC N BONI
8 Dec 23
4/A
KARL R. BOSTAPH
7 Dec 23
144
Notice of proposed sale of securities
7 Dec 23
4
OSAMA M MUSA
30 Nov 23
4
KARL R. BOSTAPH
27 Nov 23
4/A
Change in insider ownership (amended)
22 Nov 23
4/A
Change in insider ownership (amended)
22 Nov 23
4
OSAMA M MUSA
22 Nov 23
4
MIN CHONG
22 Nov 23
4
GUILLERMO NOVO
22 Nov 23
4
SWAMINATHAN ASHOK KALYANA
22 Nov 23
4
Change in insider ownership
22 Nov 23